Acumen Pharmaceuticals Inc (ABOS) stock forecast · $73.3M cap
Acumen Pharmaceuticals Inc (ABOS) is a biotechnology company listed on US.
This ABOS forecast page states what the cached financials imply — not a price target and not a guarantee. Acumen Pharmaceuticals Inc outlooks on Lician start from reported revenue and the latest filing, then you decide.
No cached income statement for ABOS yet, so there is no numeric 2026 base to extend.
Period-over-period revenue change is not in cache for ABOS, so this page does not invent a growth rate.
ABOS currently screens at market cap $73.3M. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next ABOS 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the ABOS stock page.
Not investment advice.